Spectrum Electrical Industries Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Excellent return on equity (ROE 20.4%)
- Efficient capital deployment (ROCE 16.7%)
Concerns
- High premium to book value (P/B 10.8x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| HAL Hindustan Aeronautics Limited | ₹4,856 | ₹3.2L Cr | 34.8 | 7.91 | 24 | 32 | 0 |
| BEL Bharat Electronics Limited | ₹405 | ₹3.0L Cr | 48.2 | 12.36 | 27.4 | 36.4 | 0 |
| TMCV Tata Motors Limited | ₹475 −0.03% | ₹1.7L Cr | 22.7 | 10.71 | 34 | 35.9 | 0.44 |
| ABB ABB India Limited | ₹7,410 | ₹1.6L Cr | 102 | 16.8 | 22.4 | 29.9 | 0.02 |
| BHEL Bharat Heavy Electricals Limited | ₹431 | ₹1.5L Cr | 61.7 | 5.74 | 6.23 | 9.14 | 0.45 |
| SIEMENS Siemens Limited | ₹3,977 | ₹1.4L Cr | 94.2 | 10.22 | 19.2 | 21.4 | 0.01 |
| CGPOWER CG Power and Industrial Solutions Limited | ₹891 | ₹1.4L Cr | 110 | 17.61 | 20.5 | 26.7 | 0.02 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
SPECTRUM · as of Mar 2026
| Category | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 71.45% | 71.45% | 74.88% | 72.53% | 72.53% | 72.54% |
| FII | — | — | 0.56% | 2.51% | 2.69% | 3.67% |
| DII | — | 0.07% | — | 0.31% | 0.33% | 0.34% |
| Public | 28.55% | 28.48% | 24.56% | 24.64% | 24.45% | 23.44% |
Latest News
All newsKedaara invests $200M in Tynor Orthotics
*Kedaara Capital announces $200M strategic investment in Tynor Orthotics.* This marks a significant private equity bet in the healthcare devices space. The funds will support Tynor’s expansion and product development. Terms and valuation details remain undisclosed. 📊 *STOCKS:* | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #PrivateEquity
Spectrum Electrical to hold EGM, dispatch complete
*Spectrum Electrical to hold EGM, dispatch complete.* The company has completed the dispatch of notices for its Extra-Ordinary General Meeting. The EGM is scheduled for **October 20, 2023**, at **11:00 AM**. Purpose of the meeting remains undisclosed in the filing. 📊 *STOCKS:* $SPECTRUM | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #EGM
DCM Shriram to sell stake in Serentica Renewables
*DCM Shriram to sell stake in Serentica Renewables*\nDCM Shriram Ltd. has signed a definitive agreement to divest its entire stake in Serentica Renewables. The move is part of its strategic portfolio rationalization. Financial terms were not disclosed.\n\n📊 *STOCKS:* DCMSHRIRAM | 🏢 *SECTOR:* Energy | #MEDIUMIMPACT #renewables
DCM Shriram signs deal with Serentica Renewables for renewable energy expansion
*DCM Shriram signs deal with Serentica Renewables for renewable energy expansion.* The agreement aims to jointly develop renewable energy projects, focusing on green hydrogen and solar initiatives. This strategic move supports decarbonization goals and expands DCM Shriram’s clean energy footprint. 📊 *STOCKS:* $DCMSHRIRAM | 🏢 *SECTOR:* Energy | #MEDIUMIMPACT #Renewables
FMC secures $400M strategic investment from Tessenderlo
*FMC secures $400M strategic investment from Tessenderlo Group.* This partnership aims to expand FMC’s agrochemical footprint in India. The capital will boost R&D and market reach in the agricultural sector. **$400 million** investment underscores strong foreign confidence. 📊 *STOCKS:* | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #Investment
Cadila Pharma partners Wellesta in Singapore JV
*Cadila Pharma partners Wellesta in Singapore JV.* The Indian pharma company has formed a strategic joint venture with Wellesta Holdings Singapore to expand its global footprint. The move aims to strengthen presence in Southeast Asian markets. Financial details of the JV were not disclosed. 📊 *STOCKS:* CAPELLA | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #JointVenture
Redcliffe Labs acquires Rajasthan-based diagnostic chain
*Redcliffe Labs acquires Rajasthan-based diagnostic chain* to expand its regional presence. The move strengthens its network in North India, boosting testing capacity and patient reach. Transaction size and terms not disclosed. 📊 *STOCKS:* REDCLIF | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Acquisition
Strategic acquisitions drive India's life sciences startups
*Strategic acquisitions are shaping the future of India’s life sciences startups.* This trend is fostering innovation and scaling capabilities in the sector. While no major financial figures were disclosed, the moves signal growing investor confidence. 📊 *STOCKS:* | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #Acquisitions
NCD burden may impact Viksit Bharat 2047 goals
*NCD burden may impact Viksit Bharat 2047 goals.* Rising non-communicable diseases pose a long-term challenge to India's economic vision. While not immediately market-moving, this could influence future healthcare spending and policy. **$0 Cr** direct financial impact noted. 📊 *STOCKS:* | 🏢 *SECTOR:* Macro | #LOWIMPACT #NCD
Banks redirect CSR funds to cancer infrastructure amid rising NCD burden
*Banks redirect CSR funds to cancer infrastructure amid rising NCD burden.* With non-communicable diseases on the rise, financial institutions are increasingly allocating CSR budgets toward cancer treatment facilities and early detection programs. This shift aligns with national health priorities but has **minimal direct market impact**. Sectoral focus remains on long-term social investment rather than immediate financial outcomes. 📊 *STOCKS:* | 🏢 *SECTOR:* Corporate | #LOWIMPACT #CSR